CVSCVS Health
What is the market doing?
No clear lean: rangebound and lightly shorted.
Choppy, but holding above its 200-day average. Price is +1% vs its 200-day average.
Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 11% since the previous count, down from 1.8% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CVS is trading
CVS Health is +19% over the past year while the S&P 500 is +18%: 0.46 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +0.59%
vs 200-day average · close to trend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- 22%
Below its 52-week high
Details›
- Last close2026-10-09
- $86.18
- 1 monthS&P 500 +2.7%
- −9.6%
- 1 yearS&P 500 +18%
- +19%
- 5 yearsS&P 500 +88%
- +20%
- vs 50-day average$93.20
- −7.5%
- 52-week high
- $110.58
- 52-week low
- $69.47
- Annualised volatility
- 35%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$324M
| Year | Return |
|---|---|
| 2026 (year to date) | +10% |
| 2025 | +84% |
| 2024 | −41% |
| 2023 | −13% |
| 2022 | −7.6% |
| 2021 | +55% |
| 2020 | −5.1% |
| 2019 | +17% |
| 2018 | −7.0% |
| 2017 | −5.8% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +2.4% |
| Feb | 10 | 3 of 10 | −2.6% |
| Mar | 10 | 4 of 10 | −2.0% |
| Apr | 10 | 6 of 10 | +2.5% |
| May | 10 | 4 of 10 | −1.3% |
| Jun | 10 | 6 of 10 | +2.2% |
| Jul | 11 | 6 of 11 | +1.2% |
| Aug | 11 | 6 of 11 | +1.3% |
| Sep | 11 | 6 of 11 | +0.85% |
| Oct | 11 | 4 of 11 | −2.1% |
| Nov | 10 | 7 of 10 | +6.3% |
| Dec | 10 | 4 of 10 | −2.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.